Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Aug 08, 2024

SELL
$83.81 - $99.0 $29,082 - $34,353
-347 Closed
0 $0
Q4 2023

Aug 08, 2024

SELL
$76.22 - $98.51 $12,118 - $15,663
-159 Reduced 31.42%
347 $33.5 Million
Q3 2023

Aug 08, 2024

BUY
$85.07 - $94.48 $42,194 - $46,862
496 Added 4960.0%
506 $44.8 Million
Q2 2023

Aug 08, 2024

BUY
$86.68 - $100.3 $866 - $1,003
10 New
10 $867,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Abound Wealth Management Portfolio

Follow Abound Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abound Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Abound Wealth Management with notifications on news.